World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
25582
World Ranking
16080
National Ranking
8092

Overview

Rodney L. Dunn is affiliated with the University of Michigan-Ann Arbor in the United States. Their research primarily spans the field of Medicine, with specific focus on Pulmonary and Respiratory Medicine, Economics and Econometrics, General Health Professions, Statistics and Probability, and Public Health, Environmental and Occupational Health.

The scientific output of Rodney L. Dunn covers multiple topics including:

  • Health Systems, Economic Evaluations, Quality of Life
  • Prostate Cancer Diagnosis and Treatment
  • Meta-analysis and systematic reviews
  • Pelvic floor disorders treatments
  • Prostate Cancer Treatment and Research
  • Statistical Methods in Clinical Trials
  • Reproductive Health and Technologies

Frequent collaborators in their work include James E. Montie, Brent K. Hollenbeck, Phyllis Yan, Andrew J. Vickers, and Melissa Assel.

Rodney L. Dunn has published extensively in several key medical journals. The most frequent publication venues are:

  • The Journal of Urology (18 publications)
  • Urology (7 publications)
  • Fertility and Sterility (6 publications)
  • European Urology (3 publications)
  • Journal of Clinical Oncology (3 publications)

Recent publications reflect a focus on urologic oncology and health services research with the following representative examples:

  • Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma, 2022, JAMA Network Open
  • Interstate Telehealth Use By Medicare Beneficiaries Before And After COVID-19 Licensure Waivers, 2017-20, 2022, Health Affairs
  • TrueNTH Sexual Recovery Intervention for Couples Coping with Prostate Cancer: Randomized Controlled Trial Results, 2022, Cancer
  • Evaluation of Patient- and Surgeon-Specific Variations in Patient-Reported Urinary Outcomes 3 Months After Radical Prostatectomy From a Statewide Improvement Collaborative, 2021, JAMA Surgery
  • Patient- and Surgeon-Level Variation in Patient-Reported Sexual Function Outcomes Following Radical Prostatectomy Over 2 Years, 2021, JAMA Surgery

Best Publications

  • Quality of life and satisfaction with outcome among prostate-cancer survivors.

    Martin G. Sanda;Rodney L. Dunn;Jeff Michalski;Howard M. Sandler

  • Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.

    John T Wei;Rodney L Dunn;Rodney L Dunn;Mark S Litwin;Howard M Sandler

  • Identifying risk factors for potentially avoidable complications following radical cystectomy.

    Brent K. Hollenbeck;David C. Miller;David Taub;Rodney L. Dunn

  • The relationship between modifiable health risks and health care expenditures: An analysis of the multi-employer HERO health risk and cost database

    R Z Goetzel;D R Anderson;R W Whitmer;R J Ozminkowski

  • Comprehensive Comparison of Health-Related Quality of Life After Contemporary Therapies for Localized Prostate Cancer

    John T. Wei;Rodney L. Dunn;Howard M. Sandler;P. William McLaughlin

  • Development and Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite Instrument for Measuring Health-related Quality of Life Among Prostate Cancer Survivors

    Konrad M. Szymanski;John T. Wei;Rodney L. Dunn;Martin G. Sanda

  • Trastuzumab, Paclitaxel, Carboplatin, and Gemcitabine in Advanced Human Epidermal Growth Factor Receptor-2/neu–Positive Urothelial Carcinoma: Results of a Multicenter Phase II National Cancer Institute Trial

    Maha H.A. Hussain;Gary R. MacVicar;Daniel P. Petrylak;Rodney L. Dunn

  • Effects of Raf Kinase Inhibitor Protein Expression on Suppression of Prostate Cancer Metastasis

    Zheng Fu;Peter C. Smith;Lizhi Zhang;Mark A. Rubin

  • National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization?

    Brent K. Hollenbeck;David A. Taub;David C. Miller;Rodney L. Dunn

  • Long-Term Outcomes Among Localized Prostate Cancer Survivors: Health-Related Quality-of-Life Changes After Radical Prostatectomy, External Radiation, and Brachytherapy

    David C. Miller;Martin G. Sanda;Rodney L. Dunn;James E. Montie

  • Tissue microarray sampling strategy for prostate cancer biomarker analysis.

    Mark A. Rubin;Rodney Dunn;Myla Strawderman;Kenneth J. Pienta

  • Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment

    Scott A. Tomlins;John R. Day;Robert J. Lonigro;Daniel H. Hovelson

  • Prediction of Erectile Function Following Treatment for Prostate Cancer

    Mehrdad Alemozaffar;Meredith M. Regan;Matthew R. Cooperberg;John T. Wei

  • Prospective assessment of patient reported urinary continence after radical prostatectomy.

    John T. Wei;Rodney L. Dunn;Robert Marcovich;James E. Montie

  • Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer.

    David C. Smith;Rodney L. Dunn;Myla S. Strawderman;Kenneth J. Pienta

  • Loss of CDX2 Expression and Microsatellite Instability Are Prominent Features of Large Cell Minimally Differentiated Carcinomas of the Colon

    Takao Hinoi;Masachika Tani;Masachika Tani;Peter C. Lucas;Karel Caca

  • Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form.

    Ted A Skolarus;Rodney L Dunn;Martin G Sanda;Peter Chang

  • Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer.

    Zheng Fu;Yasuhide Kitagawa;Ronglai Shen;Rajal Shah

  • Risk factors for lower urinary tract symptoms in a population-based sample of African-American men.

    Michael A. Joseph;Sioban D. Harlow;John T. Wei;Aruna V. Sarma

  • Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer

    Bruce G. Redman;Peg Esper;Quintin Pan;Rodney L. Dunn

Frequent Co-Authors

John T. Wei
John T. Wei University of Michigan–Ann Arbor
James E. Montie
James E. Montie University of Michigan–Ann Arbor
David P. Wood
David P. Wood University of Michigan–Ann Arbor
Mark S. Litwin
Mark S. Litwin University of California, Los Angeles
Howard M. Sandler
Howard M. Sandler Cedars-Sinai Medical Center
J. Stuart Wolf
J. Stuart Wolf The University of Texas at Austin
Eric A. Klein
Eric A. Klein Cleveland Clinic
Louis L. Pisters
Louis L. Pisters The University of Texas MD Anderson Cancer Center
Jeff M. Michalski
Jeff M. Michalski Washington University in St. Louis
Adam S. Kibel
Adam S. Kibel Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in alternative routes or complementing a career in Medicine, a range of online nursing degrees and pathways are available. Accelerated online programs are becoming particularly popular among students seeking greater flexibility and a faster entry into advanced healthcare roles.

Many choose accelerated dnp programs for a condensed pathway to a Doctor of Nursing Practice. These programs allow working professionals to advance their qualifications quickly.

Affordability is also an important consideration. If cost is a concern, students may wish to explore the cheapest dnp program options, which can provide significant savings while still preparing graduates for leadership roles.

Those looking for more immediate entry into nursing can consider an accelerated lpn program, which enables learners to begin working as Licensed Practical Nurses sooner.

For individuals interested in mental health, there are specialized psych np online programs that prepare graduates for advanced practice roles in psychiatric and mental health nursing—all delivered online for maximum convenience.

Best Scientists Citing Rodney L. Dunn

Trending Scientists

Recently Published Articles